Since the seminal observations made by Hotamisligil et al., demonstrating the role of adipose tissue-derived TNF as an inhibitor of insulin signalling and first linking obesity-driven inflammation to type 2 diabetes1, it is now recognised that the nature of adipose tissue inflammation is a major contributor towards obesity-related diseases2–4. Here, TNF is linked to obesity due to melanocortin 4 receptor deficiency.